H.R. 586 · Passed House · Armed Forces and National Security

Vietnam Veterans Liver Fluke Cancer Study Act

Sponsor: Nick LaLota (R-NY)

What it does

• Requires the Department of Veterans Affairs to conduct an epidemiological study on cholangiocarcinoma prevalence in Vietnam veterans.
• Mandates the VA to identify and report the incidence rate of bile duct cancer in Vietnam-era veterans compared to U.S. residents.
• Requires the VA to track cholangiocarcinoma cases using the Veterans Affairs Central Cancer Registry.
• Directs the VA to submit periodic follow-up reports to Congress on the study findings and cancer registry data.

Official summary

Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Latest action

Apr 8, 2025: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Committee: Senate Veterans' Affairs